Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1083 | 987 | 1197 | 1143 | 1400 | 1781 |
Fund Return | 8.29% | -1.31% | 19.69% | 4.57% | 6.96% | 5.94% |
Place in category | 859 | 735 | 914 | 645 | 725 | 504 |
% in Category | 37 | 35 | 40 | 36 | 47 | 53 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU2197358042 | 2.99B | 24.51 | 10.65 | - | ||
Cleome Index USA Equities R EUR Acc | 2.99B | 24.28 | 10.40 | 13.76 | ||
Cleome Index USA Equities Y EUR Acc | 2.99B | 23.18 | 9.23 | 12.90 | ||
Cleome Index USA Equities Z EUR Acc | 2.99B | 24.59 | 10.73 | 14.16 | ||
LU1434523954 | 2.18B | 13.87 | -6.81 | 4.22 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
European Growth Fund E Acc EUR | 20.91M | 11.84 | 3.35 | 4.80 | ||
European Growth Fund Y Acc EUR | 145.45M | 13.30 | 5.02 | 6.46 | ||
European Growth Fund Y DIST EUR | 65.81M | 13.33 | 5.02 | 6.47 | ||
European Growth Fund A DIST Eue | 6.58B | 12.54 | 4.13 | 5.59 | ||
European Growth Fund A Acc EUR | 159.53M | 12.55 | 4.13 | 5.59 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 3.98 | 748.9 | -3.23% | |
ASML Holding | NL0010273215 | 3.15 | 630.30 | +0.48% | |
Nestle | CH0038863350 | 2.54 | 78.00 | -1.29% | |
AstraZeneca | GB0009895292 | 2.40 | 9,990.0 | +0.05% | |
Roche Holding Participation | CH0012032048 | 2.12 | 262.50 | -1.13% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Neutral | Buy |
Technical Indicators | Strong Sell | Sell | Strong Buy |
Summary | Sell | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review